Fiche publication
Date publication
décembre 2017
Journal
Annals of translational medicine
Auteurs
Membres identifiés du Cancéropôle Est :
Dr MEUNIER-BEILLARD Nicolas
Tous les auteurs :
Quenot JP, Ecarnot F, Meunier-Beillard N, Dargent A, Large A, Andreu P, Rigaud JP
Lien Pubmed
Résumé
The decision to limit or withdraw life-support treatment is an integral part of the job of a physician working in the intensive care unit, and of the approach to care. However, this decision is influenced by a number of factors. It is widely accepted that a medical decision that will ultimate lead to end-of-life in the intensive care unit (ICU) must be shared between all those involved in the care process, and should give precedence to the patient's wishes (either directly expressed by the patient or in written form, such as advance directives), and taking into account the opinion of the patient's family, including the surrogate if the patient is no longer capable of expressing themselves. A number of questions still remain unanswered regarding how decisions to limit or withdraw treatment are taken in daily practice, especially when this decision can be anticipated. We discuss here the collegial procedure for decision-making, in particular in the context of recent French legislation on end-of-life issues. We describe how collegial decision-making procedures should be carried out, and what points are covered in shared discussions regarding decisions to limit or withdraw life-sustaining therapies.
Mots clés
Intensive care unit (ICU), end-of-life, ethics, shared decisional process
Référence
Ann Transl Med. 2017 Dec;5(Suppl 4):S43
